Autors:

CiteWeb id: 19980000146

CiteWeb score: 4054

The publication "Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program." is placed in the Top 10000 of the best publications in CiteWeb. Also in the category Other it is included to the Top 1000. Additionally, the publicaiton "Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program." is placed in the Top 1000 among other scientific works published in 1998.
Links to full text of the publication: